The agreement was signed by State Secretary for Foreign Affairs and External Economic Relations Péter Szijjártó and CEO of Egis, István Hodász. At the same time, Egis inaugurated a 4.6 billion forint (EUR 15m) R+D centre in the capital.
Mr Hodász said the strategic partnership was based on cooperation that is advantageous to both parties.
The government is ready to encourage innovation and R+D activities of Egis in Hungary, while the agreement also addresses the strengthening and the promotion of exports of own products manufactured in the plants of Egis located in Hungary, the company stated on the website of the Budapest Stock Exchange. The centre would allow Egis to develop "cutting-edge, high-potency" active ingredients.
Egis has some 530 products and about 120 active ingredients in its pharmaceutical portfolio and turns almost 140 million packs of medicines a year.
(Prime Minister’s Office)
